88 related articles for article (PubMed ID: 12091645)
1. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.8. Bone disease.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():43-8. PubMed ID: 12091645
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and management of bone disease and fractures post transplant.
Bia M
Transplant Rev (Orlando); 2008 Jan; 22(1):52-61. PubMed ID: 18631858
[TBL] [Abstract][Full Text] [Related]
4. Bone disease after renal transplantation.
Weisinger JR; Carlini RG; Rojas E; Bellorin-Font E
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1300-13. PubMed ID: 17699362
[TBL] [Abstract][Full Text] [Related]
5. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():50-5. PubMed ID: 12091650
[TBL] [Abstract][Full Text] [Related]
6. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():32, 34-6. PubMed ID: 12091641
[TBL] [Abstract][Full Text] [Related]
7. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.1. Cardiovascular risks. Cardiovascular disease after renal transplantation.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():24-5. PubMed ID: 12091628
[TBL] [Abstract][Full Text] [Related]
8. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y
Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
10. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients.
Lim WH; Coates PS; Russ GR; Coates PT
Transplantation; 2009 Sep; 88(5):678-83. PubMed ID: 19741465
[TBL] [Abstract][Full Text] [Related]
13. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
[TBL] [Abstract][Full Text] [Related]
14. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():25-6. PubMed ID: 12091630
[TBL] [Abstract][Full Text] [Related]
15. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():31-6. PubMed ID: 12091640
[TBL] [Abstract][Full Text] [Related]
16. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
[TBL] [Abstract][Full Text] [Related]
17. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia.
EBPG Expert Group on Renal Transplantation
Nephrol Dial Transplant; 2002; 17 Suppl 4():26-8. PubMed ID: 12091631
[TBL] [Abstract][Full Text] [Related]
18. Bone disease in organ transplant patients: pathogenesis and management.
Chauhan V; Ranganna KM; Chauhan N; Vaid M; Kelepouris E
Postgrad Med; 2012 May; 124(3):80-90. PubMed ID: 22691902
[TBL] [Abstract][Full Text] [Related]
19. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and patterns of bone loss in the first year after renal transplant in South East Asian patients.
Lim DS; Kee TY; Fook-Chong S; Zhang RF; Chandran M
Transplantation; 2011 Sep; 92(5):557-63. PubMed ID: 21832963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
